CG | HPG | p value | 95% CI | |
---|---|---|---|---|
Delta sCr (mmol/L) | 20 (6–51) | 25 (10–49) | 0.560 | −18 to 18 |
Delta eGFR (ml/min) | −6 (− 15–4) | − 3 (− 13–5) | 0.522 | −7 to 5 |
AKI | 16 (38%) | 19 (46%) | 0.447 | |
Dialysis | 4 (10%) | 3 (7%) | 0.565 | |
Re-operation | 4 (10%) | 1 (3%) | 0.165 | |
Stroke | 3 (8%) | 2 (5%) | 0.687 | |
4 months follow-up | ||||
Change in GFR (ml/min) | − 9 ± 12 | −5 ± 16 | 0.288 | −13 to 4 |
> 10% decrease in GFRa | 11 (44%) | 9 (39%) | 0.732 | |
30-day mortality | 3 (7%) | 3 (7%) | 1.000 | |
6-months mortality | 7 (16%) | 8 (18%) | 0.763 |